{"zip": "518057", "sector": "Healthcare", "fullTimeEmployees": 1957, "longBusinessSummary": "Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through three segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), and CDMO. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium API and enoxaparin sodium API; and other products, including pancreatin API. The company is also involved in the provision of research and development, manufacturing, quality management, and program management services; and development and manufacture of recombinant pharmaceutical products, critical non-viral vectors, intermediates for gene therapy, and naturally derived pharmaceutical products. In addition, it engages in property management, investment management and consulting, biopharmaceutical technology development and consulting, and equity and venture investment activities; research, development, and production of biopharmaceuticals; and trading of medical products. The company was formerly known as Shenzhen Hepalink Pharmaceutical Co.,Ltd. and changed its name to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in February 2017. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, China.", "city": "Shenzhen", "phone": "86 755 2698 0200", "country": "China", "companyOfficers": [], "website": "http://www.hepalink.com", "maxAge": 1, "address1": "No. 21 Langshan Road", "fax": "86 755 8614 2889", "industry": "Drug Manufacturers\u2014General", "address2": "Songpingshan Nanshan District", "ebitdaMargins": 0.21279, "profitMargins": 0.17554002, "grossMargins": 0.35299, "operatingCashflow": 675149376, "revenueGrowth": -0.096, "operatingMargins": 0.16248, "ebitda": 1105981568, "targetLowPrice": null, "recommendationKey": "none", "grossProfits": 2031927690, "freeCashflow": 471925952, "targetMedianPrice": null, "currentPrice": 15.3, "earningsGrowth": -0.522, "currentRatio": 2.783, "returnOnAssets": 0.02996, "numberOfAnalystOpinions": null, "targetMeanPrice": null, "debtToEquity": 48.682, "returnOnEquity": 0.09272, "targetHighPrice": null, "totalCash": 4845223936, "totalDebt": 5763316224, "totalRevenue": 5197638656, "totalCashPerShare": 3.302, "financialCurrency": "CNY", "revenuePerShare": 3.691, "quickRatio": 1.719, "recommendationMean": null, "exchange": "SHZ", "shortName": "SHENZHEN HEPALINK", "longName": "Shenzhen Hepalink Pharmaceutical Group Co., Ltd.", "exchangeTimezoneName": "Asia/Shanghai", "exchangeTimezoneShortName": "CST", "isEsgPopulated": false, "gmtOffSetMilliseconds": "28800000", "underlyingSymbol": null, "quoteType": "EQUITY", "symbol": "002399.SZ", "underlyingExchangeSymbol": null, "headSymbol": null, "messageBoardId": "finmb_61236432", "uuid": "8d7c6e9c-e425-3100-94f3-5445a072a99b", "market": "cn_market", "annualHoldingsTurnover": null, "enterpriseToRevenue": 4.942, "beta3Year": null, "enterpriseToEbitda": 23.226, "52WeekChange": null, "morningStarRiskRating": null, "forwardEps": null, "revenueQuarterlyGrowth": null, "sharesOutstanding": 1247200000, "fundInceptionDate": null, "annualReportExpenseRatio": null, "totalAssets": null, "bookValue": 7.987, "sharesShort": null, "sharesPercentSharesOut": null, "fundFamily": null, "lastFiscalYearEnd": 1609372800, "heldPercentInstitutions": 0.01903, "netIncomeToCommon": 912400384, "trailingEps": 0.648, "lastDividendValue": null, "SandP52WeekChange": null, "priceToBook": 1.9156129, "heldPercentInsiders": 0.79538, "nextFiscalYearEnd": 1672444800, "yield": null, "mostRecentQuarter": 1617148800, "shortRatio": null, "sharesShortPreviousMonthDate": null, "floatShares": 474127422, "beta": 0.169761, "enterpriseValue": 25687619584, "priceHint": 2, "threeYearAverageReturn": null, "lastSplitDate": 1465776000, "lastSplitFactor": "16:10", "legalType": null, "morningStarOverallRating": null, "earningsQuarterlyGrowth": -0.438, "priceToSalesTrailing12Months": 4.025787, "dateShortInterest": null, "pegRatio": null, "ytdReturn": null, "forwardPE": null, "lastCapGain": null, "shortPercentOfFloat": null, "sharesShortPriorMonth": null, "category": null, "fiveYearAverageReturn": null, "previousClose": 15.38, "regularMarketOpen": 15.29, "twoHundredDayAverage": 16.066223, "trailingAnnualDividendYield": 0.009752926, "payoutRatio": 0.277, "volume24Hr": null, "regularMarketDayHigh": 15.41, "navPrice": null, "averageDailyVolume10Day": 1863339, "regularMarketPreviousClose": 15.38, "fiftyDayAverage": 15.681945, "trailingAnnualDividendRate": 0.15, "open": 15.29, "averageVolume10days": 1863339, "expireDate": null, "algorithm": null, "dividendRate": 0.15, "exDividendDate": 1625529600, "circulatingSupply": null, "startDate": null, "regularMarketDayLow": 15.23, "currency": "CNY", "trailingPE": 23.61111, "regularMarketVolume": 601776, "lastMarket": null, "maxSupply": null, "openInterest": null, "marketCap": 20924585984, "volumeAllCurrencies": null, "strikePrice": null, "averageVolume": 4327032, "dayLow": 15.23, "ask": 15.3, "askSize": null, "volume": 601776, "fiftyTwoWeekHigh": 20.82, "fromCurrency": null, "fiveYearAvgDividendYield": null, "fiftyTwoWeekLow": 14.23, "bid": 15.29, "tradeable": false, "dividendYield": 0.0089, "bidSize": null, "dayHigh": 15.41, "regularMarketPrice": 15.3, "preMarketPrice": null, "logo_url": "https://logo.clearbit.com/hepalink.com"}